SCHEMBL4078138

SCHEMBL4078138

CCC(C)c1ccc(NC(=O)CCCC(=O)Nc2ccc(C(C)CC)cc2)cc1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.71
NPSR1 Q6W5P4 2/20 0.59
RAB9A P51151 6/20 0.54
NPC1 O15118 5/20 0.54
SMN1; SMN2 Q16637 2/20 0.54
MAPT P10636 2/20 0.54
NFKB1 P19838 1/20 0.54
NFKB2 Q00653 1/20 0.54
RELA Q04206 1/20 0.54
HTR1A P08908 3/20 0.53
HTR7 P34969 3/20 0.53
MEN1 O00255 3/20 0.52
KMT2A Q03164 3/20 0.52
POLB P06746 2/20 0.52
ALDH1A1 P00352 4/20 0.51
TP53 P04637 2/20 0.51
HDAC3 O15379 1/20 0.50
HDAC4 P56524 1/20 0.50
HDAC1 Q13547 1/20 0.50
HDAC7 Q8WUI4 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4080945 0.94 TSHR (0.64) TSHRNPSR1RAB9ANPC1SMN1; SMN2
SCHEMBL14237971 0.86 TSHR (0.76) TSHRNPSR1RAB9ANPC1SMN1; SMN2
SCHEMBL10115354 0.83 TSHR (0.54) TSHRNPSR1HTR1AHTR7MEN1
SCHEMBL2097639 0.81 TSHR (0.68) TSHRNPSR1RAB9ANPC1SMN1; SMN2
SCHEMBL2097636 0.81 TSHR (0.68) TSHRNPSR1RAB9ANPC1SMN1; SMN2
SCHEMBL9893031 0.81 TSHR (0.73) TSHRNPSR1RAB9ANPC1SMN1; SMN2
SCHEMBL10115003 0.81 TSHR (0.52) TSHRNPSR1RAB9ANPC1SMN1; SMN2
SCHEMBL18561855 0.80 TSHR (0.66) TSHRNPSR1RAB9ANPC1SMN1; SMN2
SCHEMBL9891809 0.79 TSHR (0.66) TSHRNPSR1RAB9ANPC1SMN1; SMN2
SCHEMBL23879936 0.79 EPHX1 (0.62) RAB9ANPC1SMN1; SMN2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1745010-B1 SUBSTITUTED CYCLOHEXYL-1,4-DIAMINE DERIVATIVES GRUENENTHAL GMBH (DE) 2009-08-05 EP claimed
US-20070112007-A1 Cyclohexyl-1, 4-diamine compounds GRUENENTHAL GMBH (DE) 2007-05-17 US claimed
EP-1745010-B1 SUBSTITUTED CYCLOHEXYL-1,4-DIAMINE DERIVATIVES GRUENENTHAL GMBH (DE) 2009-08-05 EP disclosed
US-20070112007-A1 Cyclohexyl-1, 4-diamine compounds GRUENENTHAL GMBH (DE) 2007-05-17 US disclosed
EP-1745010-A1 SUBSTITUTED CYCLOHEXYL-1,4-DIAMINE DERIVATIVES Grünenthal GmbH (DE) 2007-01-24 EP disclosed
WO-2005110974-A1 SUBSTITUTED CYCLOHEXYL-1,4-DIAMINE DERIVATIVES Grünenthal GmbH (DE) 2005-11-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070112007-A1 Cyclohexyl-1, 4-diamine compounds PKD1, DDC, DPYD TSHR 4464/4885NPSR1 3473/4885RAB9A 587/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.